Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong · Delayed Price · Currency is HKD
0.0930
+0.0070 (8.14%)
Jun 1, 2026, 1:20 PM HKT
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 |
|---|
Medical and Healthcare Services | | | 13.04M | 14.97M | 7.35M | 4.68M | 1.71M | | | |
Medical and Healthcare Services Growth | | | -12.90% | 103.62% | 57.02% | 173.06% | - | | | |
Chinese Medicine Business (Excluding Medical and Healthcare Services) | | | 51.80M | - | 107.55M | 112.61M | 46.20M | | | |
Chinese Medicine Business (Excluding Medical and Healthcare Services) Growth | | | - | - | -4.50% | 143.73% | - | | | |
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) | | | 471.20M | 462.64M | 396.50M | 358.06M | 444.17M | | | |
Pharmaceuticals and Medical Technologies Business (Excluding Chinese Medical Business) Growth | | | 1.85% | 16.68% | 10.74% | -19.39% | -12.38% | | | |
Elimination of Intersegment Sales | | | -3.94M | -5.14M | -1.45M | -1.02M | -614.06K | | | |
| | | - | 74.23M | - | - | - | | | |
| | | 532.09M | 546.69M | 509.96M | 474.33M | 491.48M | | | |
| | | -2.67% | 7.20% | 7.51% | -3.49% | -6.74% | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 |
|---|
| | | 524.13M | 538.11M | 505.95M | 472.39M | 489.41M | | | |
| | | -2.60% | 6.36% | 7.11% | -3.48% | -6.80% | | | |
| | | 6.47M | 7.71M | 3.64M | 1.57M | 1.40M | | | |
| | | -16.02% | 111.99% | 131.65% | 11.73% | 37.61% | | | |
| | | 1.49M | 880.00K | 366.00K | 374.32K | 664.78K | | | |
| | | 69.32% | 140.44% | -2.22% | -43.69% | -25.57% | | | |
| | | 532.09M | 546.69M | 509.96M | 474.33M | 491.48M | | | |
| | | -2.67% | 7.20% | 7.51% | -3.49% | -6.74% | | | |
Source: S&P Global Market Intelligence.
